In case you haven\u2019t heard, the creator of Dilbert has metastasized prostate cancer.<\/p>\n
Like millions of Americans, Scott Adams has also been having some issues with his insurance provider. Unlike most of his fellow citizens, though, Adams has been able to solicit the help of a cast of political Avengers.\u00a0<\/p>\n
After Adams, who lives in the East Bay, said in an X post Sunday that he has had difficulties getting a crucial drug, Pluvicto, administered by his health provider Kaiser Permanente, public and influential figures from Fannie Mae and Freddie Mac Chairman Bill Pulte, to Los Angeles Times CEO Pat Soon-Shiong, to angel investor Naval Ravikant, offered up prayers.<\/p>\n
\u201cI am declining fast,\u201d Adams wrote. \u201cI will ask President Trump if he can get Kaiser of Northern California to respond and schedule it for Monday. That will give me a fighting chance to stick around on this planet a little bit longer.\u201d<\/p>\n
The post apparently got the attention of Health and Human Services Secretary Robert F. Kennedy Jr., White House Deputy Chief of Staff Dan Scavino Jr., and Mehmet Oz, the Administrator for the Centers for Medicare and Medicaid Services, who passed the message on to the commander-in-chief himself. <\/p>\n<\/p>\n
For now, it\u2019s unclear just what kind of deal Trump can broker with Kaiser in order to help Adams. It\u2019s also unclear why, as Adams wrote on X, Kaiser \u201cdropped the ball in scheduling the brief IV to administer\u201d Pluvicto.<\/p>\n
A targeted treatment for metastatic prostate cancer administered by infusion or IV, Pluvicto was approved by the Food and Drug Administration in March for pre-chemotherapy use (opens in new tab)<\/a>. Pluvicto treatment costs over $100,000, according to the\u00a0Canadian Journal of Health Sciences (opens in new tab)<\/a>.<\/p>\n